Foundation president, Harvey Fineberg, and chairman emeritus and co-founder, Gordon Moore, discuss the Statement of Founders’ Intent with staff.
The San Francisco-based Gladstone Institutes is a research and education nonprofit dedicated to preventing, treating and curing a subset of the world’s most devastating diseases including cardiovascular disease, HIV/AIDS, and Alzheimer’s and Parkinson’s. More than 300 scientists use developmental, chemical and stem cell biology and genomics technologies to understand how disease impacts the body and to experiment with new techniques to overcome illness. Founded in 1979, Gladstone has partnered with the University of California, San Francisco since its inception, and all of the institute’s principal investigators hold faculty positions there.
The Cardiology Institute studies congenital heart disease, congestive heart failure and related metabolic disease such as diabetes. The Virology and Immunology Institute focuses on preventing viral transmission of HIV with drugs or a vaccine, curing the millions who live with HIV and restoring a normal lifespan to those who are HIV-positive. The group also researches hepatitis C and the immunology of viral infections. Neurological Institute investigators seek to move basic science discoveries into clinical trials and study the common threads that may link major neurological diseases and their treatments. The Gladstone Convergence Zone brings together scientists from varying disciplines to solve complex scientific questions and accelerate the path to cures using new approaches in imaging, single-cell analysis, nanotechnology, mass spectrometry and genome editing.
Thank you for sharing.
J. David Gladstone Institutes
Nov 2022
$3,736,651
38 months
Jun 2012
$1,513,352
41 months
Creating positive outcomes for future generations.
